Adrenal atrophy epidemiology and demographics

Jump to navigation Jump to search

Adrenal atrophy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Adrenal atrophy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Adrenal atrophy epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Adrenal atrophy epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Adrenal atrophy epidemiology and demographics

CDC on Adrenal atrophy epidemiology and demographics

Adrenal atrophy epidemiology and demographics in the news

Blogs on Adrenal atrophy epidemiology and demographics

Directions to Hospitals Treating Adrenal atrophy

Risk calculators and risk factors for Adrenal atrophy epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maryam Hadipour, M.D.[2]

Overview

Generally, secondary adrenal atrophy is more common than primary adrenal atrophy and is more common in women. Clinical manifestations occur in 30s to 50s in primary and in 60s in secondary adrenal atrophy.

Incidence

It is estimated that the incidence of the disease is 4.4 to 6 new cases per million population, annually.

Prevalence

The prevalence of primary adrenal atrophy is estimated to be 93 to 144 cases per million population. In addition, secondary adrenal atrophy is more common with estimated prevalence of 150 to 280 cases per million population. Secondary adrenal atrophy is more common among women but is mainly diagnosed in their 60s.

Generally, Adrenal atrophy is more prevalent in women and may occur in any age but the clinical manifestations mainly occur in 30s to 50s.

Mortality

The mortality of the patients with adrenal atrophy is due to the lack of adrenal stress hormones impairs the body's capacity to deal adequately with stressful situations, resulting in life-threatening adrenal crises. It is estimated that one out of 200 patients with adrenal atrophy dies from adrenal crisis each year.[1][2]

References

  1. Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dhatariya K, Dungan K, Hershman JM, Hofland J, Kalra S, Kaltsas G, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Morley JE, New M, Purnell J, Sahay R, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, Nicolaides NC, Chrousos GP, Charmandari E. PMID 25905309. Missing or empty |title= (help)
  2. Hahner S (June 2018). "Acute adrenal crisis and mortality in adrenal insufficiency: Still a concern in 2018!". Ann Endocrinol (Paris). 79 (3): 164–166. doi:10.1016/j.ando.2018.04.015. PMID 29716733.

Template:WH Template:WS